Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
28 studies found for:    "Droxidopa"
Show Display Options
Rank Status Study
1 Completed A Dose Titration of Droxidopa in Patients With Spinal Cord Injury
Conditions: Spinal Cord Injury;   Hypotension
Intervention: Drug: Droxidopa
2 Completed
Has Results
Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (Droxi-304)
Conditions: Primary Autonomic Failure;   Dopamine Beta Hydroxylase Deficiency;   Non-Diabetic Neuropathy;   Neurogenic Orthostatic Hypotension
Intervention: Drug: Droxidopa
3 Terminated
Has Results
Study To Assess The Clinical Benefit Of Droxidopa In Subjects With Chronic Fatigue Syndrome
Conditions: Chronic Fatigue Syndrome;   Orthostatic Hypotension;   Neurally Mediated Hypotension;   Neurogenic Orthostatic Hypotension
Intervention: Drug: Droxidopa
4 Terminated
Has Results
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
Conditions: Symptomatic Neurogenic Orthostatic Hypotension;   Parkinson's Disease;   Multiple Systems Atrophy;   Pure Autonomic Failure;   Dopamine Beta Hydroxylase Deficiency
Interventions: Drug: Droxidopa;   Drug: Placebo
5 Withdrawn Study to Assess Droxidopa in the Treatment of Freezing Of Gait Symptoms in Patients With Parkinson's Disease
Condition: Gait Disorders, Neurologic
Intervention: Drug: droxidopa
6 Completed Study of Droxidopa Treatment in Adults With Attention Deficit Hyperactivity Disorder With Co-administration of Carbidopa
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Droxidopa+Carbidopa;   Drug: Placebo
7 Recruiting Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Condition: Symptomatic Neurogenic Orthostatic Hypotension
Interventions: Drug: Droxidopa capsules;   Drug: Placebo capsules
8 Recruiting Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
Conditions: Autonomic Failure;   Pure Autonomic Failure;   Multiple System Atrophy;   Parkinson Disease;   Orthostatic Hypotension
Interventions: Drug: Droxidopa;   Drug: Midodrine;   Drug: Placebo
9 Enrolling by invitation Study to Assess the Clinical Benefit and Safety of Droxidopa in Parkinson's Disease
Conditions: Parkinson's Disease;   Freezing of Gait;   Cognitive Ability, General
Interventions: Drug: Droxidopa;   Drug: sugar pill
10 Recruiting Efficacy of L-threo DOPS on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With MSA
Condition: Multiple System Atrophy
Interventions: Drug: L-Threo DOPS;   Drug: placebo
11 Completed
Has Results
A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease
Conditions: Orthostatic Hypotension;   Parkinson's Disease
Interventions: Drug: Droxidopa;   Other: Placebo
12 Completed
Has Results
Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)
Conditions: Neurogenic Orthostatic Hypotension;   Non-Diabetic Autonomic Neuropathy;   Multiple System Atrophy;   Dopamine Beta Hydroxylase Deficiency
Interventions: Drug: Droxidopa;   Drug: Placebo
13 Approved for marketing Long Term Treatment With L-DOPS
Condition: Dopamine Beta Hydroxylase (DBH) Deficiency
Intervention: Drug: droxidopa
14 Completed
Has Results
Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)
Conditions: Symptomatic Neurogenic Orthostatic Hypotension (NOH);   Non-diabetic Neuropathy;   Primary Autonomic Failure;   Dopamine Beta Hydroxylase Deficiency
Interventions: Drug: Placebo;   Drug: Droxidopa
15 Withdrawn A Study of Norepinephrine in Patients With Congenital Insensitivity to Pain and Anhidrosis
Condition: HSAN Type IV
Interventions: Drug: Droxidopa (L-DOPS);   Drug: Placebo
16 Completed
Has Results
Safety and Benefit Study of Droxidopa to Treat Patients With Intradialytic Hypotension
Condition: Intradialytic Hypotension
Interventions: Drug: Droxidopa;   Drug: Placebo
17 Completed Droxidopa in Treating Patients With Neurogenic Hypotension
Conditions: Shy-Drager Syndrome;   Orthostatic Hypotension
Intervention: Drug: droxidopa
18 Completed Study of the Fed-Fast Pharmocokinetics and Bioequivalance of 300mg Capsules of Droxidopa
Condition: Symptomatic Neurogenic Orthostatic Hypotension
Intervention: Drug: Droxidopa
19 Terminated Phase 3 Study to Evaluate the Efficacy and Safety of Droxidopa on Orthostatic Hypotension Treatment in Hemodialysis Patients
Condition: Orthostatic Hypotension
Interventions: Drug: Droxidopa;   Drug: Placebo
20 Recruiting Northera Improves Postural Tachycardia Syndrome (POTS) and Postural Vasovagal Syncope (VVS)
Conditions: Postural Tachycardia Syndrome (POTS);   Vasovagal Syncope (VVS);   Fainting
Interventions: Drug: Northera (Droxidopa);   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.